Antibacterial Therapy and Newer Agents, An Issue of Infectious Disease Clinics, 1st Edition
Author :
By Keith S. Kaye, MD, MPH and Donald Kaye, MD, MACP
Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid chang
...view more
Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid changes in therapeutic approaches, especially in the use of antimicrobial agents. This issue covers antibiotics in specific populations (children, the elderly, and patients with renal failure), antimicrobial resistance, and new drugs in several classes, including macrolides, fluoroquinolones, beta-lactam antibiotics, and agents for gram-positive infections.
Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid changes in therapeutic approaches, especially in the use of antimicrobial agents. This issue covers antibiotics in specific populations (children, the elderly, and patients with renal failure), antimicrobial resistance, and new drugs in several classes, including macrolides, fluoroquinolones, beta-lactam antibiotics, and agents for gram-positive infections.
Author Information
By Keith S. Kaye, MD, MPH and Donald Kaye, MD, MACP
https://www.asia.elsevierhealth.com/antibacterial-therapy-and-newer-agents-an-issue-of-infectious-disease-clinics-9781437712322.html299575Antibacterial Therapy and Newer Agents, An Issue of Infectious Disease Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png89.0998.99USDInStock/Medicine & Surgery/Infectious Disease/Clinics/Medicine/Infectious Disease/Clinics/Clinics/Medicine/Infectious Disease/Japan Titles43351464388725505462350546665255041525986052631601418269243350884886536505455351451205259833Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid changes in therapeutic approaches, especially in the use of antimicrobial agents. This issue covers antibiotics in specific populations (children, the elderly, and patients with renal failure), antimicrobial resistance, and new drugs in several classes, including macrolides, fluoroquinolones, beta-lactam antibiotics, and agents for gram-positive infections. Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid changes in therapeutic approaches, especially in the use of antimicrobial agents. This issue covers antibiotics in specific populations (children, the elderly, and patients with renal failure), antimicrobial resistance, and new drugs in several classes, including macrolides, fluoroquinolones, beta-lactam antibiotics, and agents for gram-positive infections.00add-to-cart97814377123222011 and earlierProfessionalBy Keith S. Kaye, MD, MPH and Donald Kaye, MD, MACP20091BookOtherSaunders0Dec 11, 2009IN STOCKBy <STRONG>Keith S. Kaye</STRONG>, MD, MPH and <STRONG>Donald Kaye</STRONG>, MD, MACPClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select